The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
Having a concierge dietician on-site at the clinic is another advantage for Formation patients
Serious adverse events were similar to semaglutide
Study Duration: DSIP may be administered on as-needed basis Notes: One 5mg spray bottle comprises 100 sprays, so would last just under 17 days of administration per test subject
However, despite this localized overproduction, the total systemic burden of free radicals remains too high, leading to inevitable cellular exhaustion and highlighting the desperate need for targeted antioxidant support
It has been extensively studied for wound healing, skin rejuvenation, and tissue remodeling